nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—UGT2B7—Epirubicin—stomach cancer	0.257	0.426	CbGbCtD
Silodosin—ABCB1—Mitomycin—stomach cancer	0.167	0.277	CbGbCtD
Silodosin—ABCB4—bile—stomach cancer	0.0616	0.448	CbGeAlD
Silodosin—ABCB1—Irinotecan—stomach cancer	0.0428	0.0711	CbGbCtD
Silodosin—ABCB1—Docetaxel—stomach cancer	0.0314	0.0521	CbGbCtD
Silodosin—CYP3A4—Irinotecan—stomach cancer	0.0257	0.0426	CbGbCtD
Silodosin—ABCB1—Doxorubicin—stomach cancer	0.0234	0.0388	CbGbCtD
Silodosin—ABCB1—Methotrexate—stomach cancer	0.0227	0.0376	CbGbCtD
Silodosin—CYP3A4—Docetaxel—stomach cancer	0.0188	0.0312	CbGbCtD
Silodosin—ABCB4—gall bladder—stomach cancer	0.0171	0.124	CbGeAlD
Silodosin—CYP3A4—Doxorubicin—stomach cancer	0.014	0.0233	CbGbCtD
Silodosin—ABCB4—hematopoietic system—stomach cancer	0.00968	0.0704	CbGeAlD
Silodosin—ABCB4—endocrine gland—stomach cancer	0.00556	0.0405	CbGeAlD
Silodosin—ABCB4—liver—stomach cancer	0.00502	0.0365	CbGeAlD
Silodosin—ABCB4—lymph node—stomach cancer	0.00385	0.028	CbGeAlD
Silodosin—ADRA1D—epithelium—stomach cancer	0.00359	0.0261	CbGeAlD
Silodosin—UGT2B7—digestive system—stomach cancer	0.00345	0.0251	CbGeAlD
Silodosin—Tamsulosin—HTR1A—stomach cancer	0.00309	1	CrCbGaD
Silodosin—UGT2B7—endocrine gland—stomach cancer	0.00285	0.0207	CbGeAlD
Silodosin—UGT2B7—liver—stomach cancer	0.00257	0.0187	CbGeAlD
Silodosin—ADRA1D—endocrine gland—stomach cancer	0.00226	0.0164	CbGeAlD
Silodosin—ADRA1A—hematopoietic system—stomach cancer	0.00226	0.0164	CbGeAlD
Silodosin—Swelling face—Capecitabine—stomach cancer	0.00218	0.0208	CcSEcCtD
Silodosin—ADRA1A—epithelium—stomach cancer	0.00206	0.015	CbGeAlD
Silodosin—ABCB1—blood vessel—stomach cancer	0.0018	0.0131	CbGeAlD
Silodosin—Nervous system disorder—Floxuridine—stomach cancer	0.00159	0.0152	CcSEcCtD
Silodosin—ADRA1A—lymphoid tissue—stomach cancer	0.00159	0.0116	CbGeAlD
Silodosin—Syncope—Mitomycin—stomach cancer	0.0014	0.0134	CcSEcCtD
Silodosin—Loss of consciousness—Mitomycin—stomach cancer	0.00137	0.0131	CcSEcCtD
Silodosin—CYP3A4—hematopoietic system—stomach cancer	0.00135	0.00982	CbGeAlD
Silodosin—Gastrointestinal pain—Floxuridine—stomach cancer	0.00133	0.0127	CcSEcCtD
Silodosin—Rhinorrhoea—Docetaxel—stomach cancer	0.00132	0.0127	CcSEcCtD
Silodosin—ADRA1A—endocrine gland—stomach cancer	0.0013	0.00943	CbGeAlD
Silodosin—Abdominal pain—Floxuridine—stomach cancer	0.00128	0.0123	CcSEcCtD
Silodosin—Rhinorrhoea—Capecitabine—stomach cancer	0.00128	0.0123	CcSEcCtD
Silodosin—Shock—Mitomycin—stomach cancer	0.00125	0.012	CcSEcCtD
Silodosin—ADRA1A—liver—stomach cancer	0.00117	0.0085	CbGeAlD
Silodosin—Asthenia—Floxuridine—stomach cancer	0.00117	0.0111	CcSEcCtD
Silodosin—Diarrhoea—Floxuridine—stomach cancer	0.00111	0.0106	CcSEcCtD
Silodosin—Orthostatic hypotension—Irinotecan—stomach cancer	0.00103	0.00983	CcSEcCtD
Silodosin—Rash—Floxuridine—stomach cancer	0.00102	0.00979	CcSEcCtD
Silodosin—Dermatitis—Floxuridine—stomach cancer	0.00102	0.00978	CcSEcCtD
Silodosin—Headache—Floxuridine—stomach cancer	0.00102	0.00973	CcSEcCtD
Silodosin—Nausea—Floxuridine—stomach cancer	0.000965	0.00922	CcSEcCtD
Silodosin—Nasopharyngitis—Fluorouracil—stomach cancer	0.000965	0.00922	CcSEcCtD
Silodosin—ABCB1—hematopoietic system—stomach cancer	0.000956	0.00695	CbGeAlD
Silodosin—CYP3A4—digestive system—stomach cancer	0.000939	0.00683	CbGeAlD
Silodosin—Asthenia—Mitomycin—stomach cancer	0.000915	0.00874	CcSEcCtD
Silodosin—ABCB1—epithelium—stomach cancer	0.000874	0.00636	CbGeAlD
Silodosin—Diarrhoea—Mitomycin—stomach cancer	0.000872	0.00834	CcSEcCtD
Silodosin—Hepatic function abnormal—Capecitabine—stomach cancer	0.000863	0.00824	CcSEcCtD
Silodosin—Jaundice—Irinotecan—stomach cancer	0.000846	0.00809	CcSEcCtD
Silodosin—Dizziness—Mitomycin—stomach cancer	0.000843	0.00806	CcSEcCtD
Silodosin—Vascular purpura—Capecitabine—stomach cancer	0.000843	0.00805	CcSEcCtD
Silodosin—Libido decreased—Capecitabine—stomach cancer	0.000813	0.00777	CcSEcCtD
Silodosin—Rash—Mitomycin—stomach cancer	0.000804	0.00768	CcSEcCtD
Silodosin—Dermatitis—Mitomycin—stomach cancer	0.000803	0.00767	CcSEcCtD
Silodosin—Headache—Mitomycin—stomach cancer	0.000799	0.00763	CcSEcCtD
Silodosin—Purpura—Capecitabine—stomach cancer	0.000782	0.00748	CcSEcCtD
Silodosin—Sinusitis—Fluorouracil—stomach cancer	0.00078	0.00745	CcSEcCtD
Silodosin—ABCB1—pancreas—stomach cancer	0.000779	0.00566	CbGeAlD
Silodosin—CYP3A4—endocrine gland—stomach cancer	0.000776	0.00565	CbGeAlD
Silodosin—Nausea—Mitomycin—stomach cancer	0.000757	0.00724	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Capecitabine—stomach cancer	0.000748	0.00715	CcSEcCtD
Silodosin—Cardiac disorder—Irinotecan—stomach cancer	0.000723	0.00691	CcSEcCtD
Silodosin—Liver function test abnormal—Docetaxel—stomach cancer	0.000719	0.00687	CcSEcCtD
Silodosin—Orthostatic hypotension—Docetaxel—stomach cancer	0.000711	0.0068	CcSEcCtD
Silodosin—Angiopathy—Irinotecan—stomach cancer	0.000707	0.00676	CcSEcCtD
Silodosin—Immune system disorder—Irinotecan—stomach cancer	0.000704	0.00673	CcSEcCtD
Silodosin—Breast disorder—Docetaxel—stomach cancer	0.000704	0.00672	CcSEcCtD
Silodosin—Mediastinal disorder—Irinotecan—stomach cancer	0.000702	0.00671	CcSEcCtD
Silodosin—CYP3A4—liver—stomach cancer	0.0007	0.00509	CbGeAlD
Silodosin—Nasopharyngitis—Docetaxel—stomach cancer	0.000696	0.00665	CcSEcCtD
Silodosin—Liver function test abnormal—Capecitabine—stomach cancer	0.000696	0.00665	CcSEcCtD
Silodosin—Orthostatic hypotension—Capecitabine—stomach cancer	0.000689	0.00658	CcSEcCtD
Silodosin—Breast disorder—Capecitabine—stomach cancer	0.000681	0.00651	CcSEcCtD
Silodosin—Nasopharyngitis—Capecitabine—stomach cancer	0.000674	0.00644	CcSEcCtD
Silodosin—ABCB1—lymphoid tissue—stomach cancer	0.000673	0.0049	CbGeAlD
Silodosin—ABCB1—digestive system—stomach cancer	0.000665	0.00484	CbGeAlD
Silodosin—ABCB1—bone marrow—stomach cancer	0.000613	0.00446	CbGeAlD
Silodosin—Syncope—Irinotecan—stomach cancer	0.000608	0.00581	CcSEcCtD
Silodosin—Hepatic function abnormal—Epirubicin—stomach cancer	0.000601	0.00574	CcSEcCtD
Silodosin—Loss of consciousness—Irinotecan—stomach cancer	0.000596	0.0057	CcSEcCtD
Silodosin—Vascular purpura—Epirubicin—stomach cancer	0.000587	0.00561	CcSEcCtD
Silodosin—Jaundice—Docetaxel—stomach cancer	0.000585	0.00559	CcSEcCtD
Silodosin—Hepatobiliary disease—Docetaxel—stomach cancer	0.000568	0.00542	CcSEcCtD
Silodosin—Jaundice—Capecitabine—stomach cancer	0.000566	0.00541	CcSEcCtD
Silodosin—Hepatic function abnormal—Doxorubicin—stomach cancer	0.000556	0.00531	CcSEcCtD
Silodosin—Hepatobiliary disease—Capecitabine—stomach cancer	0.00055	0.00525	CcSEcCtD
Silodosin—ABCB1—endocrine gland—stomach cancer	0.000549	0.004	CbGeAlD
Silodosin—Purpura—Epirubicin—stomach cancer	0.000545	0.00521	CcSEcCtD
Silodosin—Shock—Irinotecan—stomach cancer	0.000545	0.00521	CcSEcCtD
Silodosin—Vascular purpura—Doxorubicin—stomach cancer	0.000543	0.00519	CcSEcCtD
Silodosin—Nervous system disorder—Irinotecan—stomach cancer	0.000543	0.00519	CcSEcCtD
Silodosin—Nervous system disorder—Fluorouracil—stomach cancer	0.00052	0.00497	CcSEcCtD
Silodosin—Liver function test abnormal—Methotrexate—stomach cancer	0.000518	0.00495	CcSEcCtD
Silodosin—Tachycardia—Fluorouracil—stomach cancer	0.000518	0.00495	CcSEcCtD
Silodosin—Hypotension—Irinotecan—stomach cancer	0.000517	0.00494	CcSEcCtD
Silodosin—Breast disorder—Methotrexate—stomach cancer	0.000507	0.00485	CcSEcCtD
Silodosin—Purpura—Doxorubicin—stomach cancer	0.000504	0.00482	CcSEcCtD
Silodosin—Insomnia—Irinotecan—stomach cancer	0.000501	0.00479	CcSEcCtD
Silodosin—Cardiac disorder—Docetaxel—stomach cancer	0.0005	0.00478	CcSEcCtD
Silodosin—Hypotension—Fluorouracil—stomach cancer	0.000496	0.00474	CcSEcCtD
Silodosin—ABCB1—liver—stomach cancer	0.000495	0.0036	CbGeAlD
Silodosin—Angiopathy—Docetaxel—stomach cancer	0.000489	0.00467	CcSEcCtD
Silodosin—Immune system disorder—Docetaxel—stomach cancer	0.000487	0.00465	CcSEcCtD
Silodosin—Mediastinal disorder—Docetaxel—stomach cancer	0.000486	0.00464	CcSEcCtD
Silodosin—Liver function test abnormal—Epirubicin—stomach cancer	0.000485	0.00463	CcSEcCtD
Silodosin—Cardiac disorder—Capecitabine—stomach cancer	0.000484	0.00463	CcSEcCtD
Silodosin—Orthostatic hypotension—Epirubicin—stomach cancer	0.00048	0.00458	CcSEcCtD
Silodosin—Insomnia—Fluorouracil—stomach cancer	0.00048	0.00458	CcSEcCtD
Silodosin—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000478	0.00457	CcSEcCtD
Silodosin—Breast disorder—Epirubicin—stomach cancer	0.000475	0.00454	CcSEcCtD
Silodosin—Angiopathy—Capecitabine—stomach cancer	0.000473	0.00452	CcSEcCtD
Silodosin—Mental disorder—Docetaxel—stomach cancer	0.000472	0.00451	CcSEcCtD
Silodosin—Immune system disorder—Capecitabine—stomach cancer	0.000471	0.0045	CcSEcCtD
Silodosin—Mediastinal disorder—Capecitabine—stomach cancer	0.00047	0.00449	CcSEcCtD
Silodosin—Nasopharyngitis—Epirubicin—stomach cancer	0.00047	0.00449	CcSEcCtD
Silodosin—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000458	0.00438	CcSEcCtD
Silodosin—Mental disorder—Capecitabine—stomach cancer	0.000457	0.00437	CcSEcCtD
Silodosin—Gastrointestinal pain—Irinotecan—stomach cancer	0.000453	0.00433	CcSEcCtD
Silodosin—Liver function test abnormal—Doxorubicin—stomach cancer	0.000449	0.00429	CcSEcCtD
Silodosin—Erectile dysfunction—Methotrexate—stomach cancer	0.000447	0.00427	CcSEcCtD
Silodosin—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000444	0.00424	CcSEcCtD
Silodosin—Breast disorder—Doxorubicin—stomach cancer	0.000439	0.0042	CcSEcCtD
Silodosin—Abdominal pain—Irinotecan—stomach cancer	0.000438	0.00418	CcSEcCtD
Silodosin—Nasopharyngitis—Doxorubicin—stomach cancer	0.000435	0.00415	CcSEcCtD
Silodosin—Urticaria—Fluorouracil—stomach cancer	0.000421	0.00403	CcSEcCtD
Silodosin—Syncope—Docetaxel—stomach cancer	0.000421	0.00402	CcSEcCtD
Silodosin—Palpitations—Docetaxel—stomach cancer	0.000414	0.00396	CcSEcCtD
Silodosin—Loss of consciousness—Docetaxel—stomach cancer	0.000412	0.00394	CcSEcCtD
Silodosin—Hepatobiliary disease—Methotrexate—stomach cancer	0.000409	0.00391	CcSEcCtD
Silodosin—Syncope—Capecitabine—stomach cancer	0.000407	0.00389	CcSEcCtD
Silodosin—Palpitations—Capecitabine—stomach cancer	0.000401	0.00383	CcSEcCtD
Silodosin—Loss of consciousness—Capecitabine—stomach cancer	0.000399	0.00381	CcSEcCtD
Silodosin—Asthenia—Irinotecan—stomach cancer	0.000397	0.0038	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000397	0.00379	CcSEcCtD
Silodosin—Jaundice—Epirubicin—stomach cancer	0.000395	0.00377	CcSEcCtD
Silodosin—Dry mouth—Docetaxel—stomach cancer	0.000391	0.00373	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000384	0.00367	CcSEcCtD
Silodosin—Hepatobiliary disease—Epirubicin—stomach cancer	0.000383	0.00366	CcSEcCtD
Silodosin—ABCB1—lymph node—stomach cancer	0.00038	0.00276	CbGeAlD
Silodosin—Sinusitis—Epirubicin—stomach cancer	0.00038	0.00363	CcSEcCtD
Silodosin—Diarrhoea—Irinotecan—stomach cancer	0.000379	0.00362	CcSEcCtD
Silodosin—Dry mouth—Capecitabine—stomach cancer	0.000378	0.00361	CcSEcCtD
Silodosin—Shock—Docetaxel—stomach cancer	0.000377	0.0036	CcSEcCtD
Silodosin—Nervous system disorder—Docetaxel—stomach cancer	0.000375	0.00359	CcSEcCtD
Silodosin—Pruritus—Fluorouracil—stomach cancer	0.000375	0.00359	CcSEcCtD
Silodosin—Tachycardia—Docetaxel—stomach cancer	0.000374	0.00357	CcSEcCtD
Silodosin—Skin disorder—Docetaxel—stomach cancer	0.000372	0.00355	CcSEcCtD
Silodosin—Dizziness—Irinotecan—stomach cancer	0.000366	0.0035	CcSEcCtD
Silodosin—Jaundice—Doxorubicin—stomach cancer	0.000365	0.00349	CcSEcCtD
Silodosin—Shock—Capecitabine—stomach cancer	0.000365	0.00348	CcSEcCtD
Silodosin—Nervous system disorder—Capecitabine—stomach cancer	0.000363	0.00347	CcSEcCtD
Silodosin—Diarrhoea—Fluorouracil—stomach cancer	0.000363	0.00347	CcSEcCtD
Silodosin—Tachycardia—Capecitabine—stomach cancer	0.000362	0.00346	CcSEcCtD
Silodosin—Cardiac disorder—Methotrexate—stomach cancer	0.00036	0.00344	CcSEcCtD
Silodosin—Skin disorder—Capecitabine—stomach cancer	0.00036	0.00344	CcSEcCtD
Silodosin—Hypotension—Docetaxel—stomach cancer	0.000358	0.00342	CcSEcCtD
Silodosin—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000354	0.00338	CcSEcCtD
Silodosin—Angiopathy—Methotrexate—stomach cancer	0.000352	0.00337	CcSEcCtD
Silodosin—Sinusitis—Doxorubicin—stomach cancer	0.000351	0.00336	CcSEcCtD
Silodosin—Immune system disorder—Methotrexate—stomach cancer	0.000351	0.00335	CcSEcCtD
Silodosin—Dizziness—Fluorouracil—stomach cancer	0.000351	0.00335	CcSEcCtD
Silodosin—Mediastinal disorder—Methotrexate—stomach cancer	0.00035	0.00334	CcSEcCtD
Silodosin—Rash—Irinotecan—stomach cancer	0.000349	0.00334	CcSEcCtD
Silodosin—Dermatitis—Irinotecan—stomach cancer	0.000349	0.00333	CcSEcCtD
Silodosin—Headache—Irinotecan—stomach cancer	0.000347	0.00331	CcSEcCtD
Silodosin—Hypotension—Capecitabine—stomach cancer	0.000346	0.00331	CcSEcCtD
Silodosin—Insomnia—Docetaxel—stomach cancer	0.000346	0.00331	CcSEcCtD
Silodosin—Mental disorder—Methotrexate—stomach cancer	0.00034	0.00325	CcSEcCtD
Silodosin—Cardiac disorder—Epirubicin—stomach cancer	0.000337	0.00322	CcSEcCtD
Silodosin—Insomnia—Capecitabine—stomach cancer	0.000335	0.0032	CcSEcCtD
Silodosin—Rash—Fluorouracil—stomach cancer	0.000334	0.0032	CcSEcCtD
Silodosin—Dermatitis—Fluorouracil—stomach cancer	0.000334	0.00319	CcSEcCtD
Silodosin—Headache—Fluorouracil—stomach cancer	0.000332	0.00317	CcSEcCtD
Silodosin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00033	0.00316	CcSEcCtD
Silodosin—Angiopathy—Epirubicin—stomach cancer	0.00033	0.00315	CcSEcCtD
Silodosin—Nausea—Irinotecan—stomach cancer	0.000329	0.00314	CcSEcCtD
Silodosin—Immune system disorder—Epirubicin—stomach cancer	0.000328	0.00314	CcSEcCtD
Silodosin—Mediastinal disorder—Epirubicin—stomach cancer	0.000328	0.00313	CcSEcCtD
Silodosin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00032	0.00306	CcSEcCtD
Silodosin—Mental disorder—Epirubicin—stomach cancer	0.000318	0.00304	CcSEcCtD
Silodosin—Nausea—Fluorouracil—stomach cancer	0.000315	0.00301	CcSEcCtD
Silodosin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000313	0.00299	CcSEcCtD
Silodosin—Cardiac disorder—Doxorubicin—stomach cancer	0.000312	0.00298	CcSEcCtD
Silodosin—Angiopathy—Doxorubicin—stomach cancer	0.000305	0.00292	CcSEcCtD
Silodosin—Immune system disorder—Doxorubicin—stomach cancer	0.000304	0.0029	CcSEcCtD
Silodosin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000303	0.0029	CcSEcCtD
Silodosin—Mediastinal disorder—Doxorubicin—stomach cancer	0.000303	0.0029	CcSEcCtD
Silodosin—Abdominal pain—Docetaxel—stomach cancer	0.000303	0.00289	CcSEcCtD
Silodosin—Mental disorder—Doxorubicin—stomach cancer	0.000295	0.00281	CcSEcCtD
Silodosin—Urticaria—Capecitabine—stomach cancer	0.000294	0.00281	CcSEcCtD
Silodosin—Abdominal pain—Capecitabine—stomach cancer	0.000293	0.0028	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000286	0.00273	CcSEcCtD
Silodosin—Syncope—Epirubicin—stomach cancer	0.000284	0.00271	CcSEcCtD
Silodosin—Palpitations—Epirubicin—stomach cancer	0.00028	0.00267	CcSEcCtD
Silodosin—Loss of consciousness—Epirubicin—stomach cancer	0.000278	0.00266	CcSEcCtD
Silodosin—Asthenia—Docetaxel—stomach cancer	0.000275	0.00262	CcSEcCtD
Silodosin—Pruritus—Docetaxel—stomach cancer	0.000271	0.00259	CcSEcCtD
Silodosin—Nervous system disorder—Methotrexate—stomach cancer	0.000271	0.00259	CcSEcCtD
Silodosin—Skin disorder—Methotrexate—stomach cancer	0.000268	0.00256	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000267	0.00256	CcSEcCtD
Silodosin—Asthenia—Capecitabine—stomach cancer	0.000266	0.00254	CcSEcCtD
Silodosin—Dry mouth—Epirubicin—stomach cancer	0.000263	0.00252	CcSEcCtD
Silodosin—Syncope—Doxorubicin—stomach cancer	0.000262	0.00251	CcSEcCtD
Silodosin—Pruritus—Capecitabine—stomach cancer	0.000262	0.00251	CcSEcCtD
Silodosin—Diarrhoea—Docetaxel—stomach cancer	0.000262	0.0025	CcSEcCtD
Silodosin—Palpitations—Doxorubicin—stomach cancer	0.000259	0.00247	CcSEcCtD
Silodosin—Hypotension—Methotrexate—stomach cancer	0.000258	0.00246	CcSEcCtD
Silodosin—Loss of consciousness—Doxorubicin—stomach cancer	0.000257	0.00246	CcSEcCtD
Silodosin—Shock—Epirubicin—stomach cancer	0.000254	0.00243	CcSEcCtD
Silodosin—Diarrhoea—Capecitabine—stomach cancer	0.000254	0.00242	CcSEcCtD
Silodosin—Nervous system disorder—Epirubicin—stomach cancer	0.000253	0.00242	CcSEcCtD
Silodosin—Dizziness—Docetaxel—stomach cancer	0.000253	0.00242	CcSEcCtD
Silodosin—Tachycardia—Epirubicin—stomach cancer	0.000252	0.00241	CcSEcCtD
Silodosin—Skin disorder—Epirubicin—stomach cancer	0.000251	0.0024	CcSEcCtD
Silodosin—Insomnia—Methotrexate—stomach cancer	0.00025	0.00238	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000247	0.00236	CcSEcCtD
Silodosin—Dizziness—Capecitabine—stomach cancer	0.000245	0.00234	CcSEcCtD
Silodosin—Dry mouth—Doxorubicin—stomach cancer	0.000244	0.00233	CcSEcCtD
Silodosin—Rash—Docetaxel—stomach cancer	0.000241	0.00231	CcSEcCtD
Silodosin—Hypotension—Epirubicin—stomach cancer	0.000241	0.00231	CcSEcCtD
Silodosin—Dermatitis—Docetaxel—stomach cancer	0.000241	0.0023	CcSEcCtD
Silodosin—Headache—Docetaxel—stomach cancer	0.00024	0.00229	CcSEcCtD
Silodosin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000238	0.00228	CcSEcCtD
Silodosin—Shock—Doxorubicin—stomach cancer	0.000235	0.00225	CcSEcCtD
Silodosin—Nervous system disorder—Doxorubicin—stomach cancer	0.000234	0.00224	CcSEcCtD
Silodosin—Rash—Capecitabine—stomach cancer	0.000234	0.00223	CcSEcCtD
Silodosin—Insomnia—Epirubicin—stomach cancer	0.000234	0.00223	CcSEcCtD
Silodosin—Dermatitis—Capecitabine—stomach cancer	0.000233	0.00223	CcSEcCtD
Silodosin—Tachycardia—Doxorubicin—stomach cancer	0.000233	0.00223	CcSEcCtD
Silodosin—Headache—Capecitabine—stomach cancer	0.000232	0.00222	CcSEcCtD
Silodosin—Skin disorder—Doxorubicin—stomach cancer	0.000232	0.00222	CcSEcCtD
Silodosin—Nausea—Docetaxel—stomach cancer	0.000227	0.00217	CcSEcCtD
Silodosin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000226	0.00216	CcSEcCtD
Silodosin—Hypotension—Doxorubicin—stomach cancer	0.000223	0.00213	CcSEcCtD
Silodosin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000223	0.00213	CcSEcCtD
Silodosin—Nausea—Capecitabine—stomach cancer	0.00022	0.0021	CcSEcCtD
Silodosin—Urticaria—Methotrexate—stomach cancer	0.000219	0.00209	CcSEcCtD
Silodosin—Abdominal pain—Methotrexate—stomach cancer	0.000218	0.00208	CcSEcCtD
Silodosin—Insomnia—Doxorubicin—stomach cancer	0.000216	0.00206	CcSEcCtD
Silodosin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000211	0.00202	CcSEcCtD
Silodosin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000206	0.00197	CcSEcCtD
Silodosin—Urticaria—Epirubicin—stomach cancer	0.000205	0.00196	CcSEcCtD
Silodosin—Abdominal pain—Epirubicin—stomach cancer	0.000204	0.00195	CcSEcCtD
Silodosin—Asthenia—Methotrexate—stomach cancer	0.000198	0.00189	CcSEcCtD
Silodosin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000195	0.00187	CcSEcCtD
Silodosin—Pruritus—Methotrexate—stomach cancer	0.000195	0.00187	CcSEcCtD
Silodosin—Urticaria—Doxorubicin—stomach cancer	0.00019	0.00181	CcSEcCtD
Silodosin—Abdominal pain—Doxorubicin—stomach cancer	0.000189	0.0018	CcSEcCtD
Silodosin—Diarrhoea—Methotrexate—stomach cancer	0.000189	0.0018	CcSEcCtD
Silodosin—Asthenia—Epirubicin—stomach cancer	0.000185	0.00177	CcSEcCtD
Silodosin—Pruritus—Epirubicin—stomach cancer	0.000183	0.00175	CcSEcCtD
Silodosin—Dizziness—Methotrexate—stomach cancer	0.000182	0.00174	CcSEcCtD
Silodosin—Diarrhoea—Epirubicin—stomach cancer	0.000177	0.00169	CcSEcCtD
Silodosin—Rash—Methotrexate—stomach cancer	0.000174	0.00166	CcSEcCtD
Silodosin—Dermatitis—Methotrexate—stomach cancer	0.000174	0.00166	CcSEcCtD
Silodosin—Headache—Methotrexate—stomach cancer	0.000173	0.00165	CcSEcCtD
Silodosin—Asthenia—Doxorubicin—stomach cancer	0.000171	0.00164	CcSEcCtD
Silodosin—Dizziness—Epirubicin—stomach cancer	0.000171	0.00163	CcSEcCtD
Silodosin—Pruritus—Doxorubicin—stomach cancer	0.000169	0.00162	CcSEcCtD
Silodosin—Nausea—Methotrexate—stomach cancer	0.000164	0.00157	CcSEcCtD
Silodosin—Diarrhoea—Doxorubicin—stomach cancer	0.000163	0.00156	CcSEcCtD
Silodosin—Rash—Epirubicin—stomach cancer	0.000163	0.00156	CcSEcCtD
Silodosin—Dermatitis—Epirubicin—stomach cancer	0.000163	0.00155	CcSEcCtD
Silodosin—Headache—Epirubicin—stomach cancer	0.000162	0.00155	CcSEcCtD
Silodosin—Dizziness—Doxorubicin—stomach cancer	0.000158	0.00151	CcSEcCtD
Silodosin—Nausea—Epirubicin—stomach cancer	0.000153	0.00147	CcSEcCtD
Silodosin—Rash—Doxorubicin—stomach cancer	0.000151	0.00144	CcSEcCtD
Silodosin—Dermatitis—Doxorubicin—stomach cancer	0.00015	0.00144	CcSEcCtD
Silodosin—Headache—Doxorubicin—stomach cancer	0.00015	0.00143	CcSEcCtD
Silodosin—Nausea—Doxorubicin—stomach cancer	0.000142	0.00136	CcSEcCtD
Silodosin—ADRA1B—Signaling Pathways—HSPB1—stomach cancer	3.04e-05	0.0002	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	3.02e-05	0.000199	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—BMP2—stomach cancer	3e-05	0.000198	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—F2R—stomach cancer	3e-05	0.000198	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—FADS1—stomach cancer	2.99e-05	0.000197	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TYMP—stomach cancer	2.99e-05	0.000197	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKR1C3—stomach cancer	2.96e-05	0.000195	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.94e-05	0.000193	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HTR1A—stomach cancer	2.92e-05	0.000192	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CAV1—stomach cancer	2.92e-05	0.000192	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—APOA1—stomach cancer	2.92e-05	0.000192	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.9e-05	0.000191	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HBEGF—stomach cancer	2.89e-05	0.00019	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.87e-05	0.000189	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.87e-05	0.000189	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PRKCB—stomach cancer	2.83e-05	0.000186	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ANXA1—stomach cancer	2.82e-05	0.000186	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SREBF2—stomach cancer	2.8e-05	0.000184	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—RORA—stomach cancer	2.77e-05	0.000182	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL6R—stomach cancer	2.75e-05	0.000181	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—RHOA—stomach cancer	2.74e-05	0.00018	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRB1—stomach cancer	2.74e-05	0.00018	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.73e-05	0.00018	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.71e-05	0.000179	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AGTR2—stomach cancer	2.7e-05	0.000178	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HSPB1—stomach cancer	2.7e-05	0.000178	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADRB2—stomach cancer	2.67e-05	0.000176	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—F2R—stomach cancer	2.67e-05	0.000176	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—BMP2—stomach cancer	2.67e-05	0.000176	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKR1C3—stomach cancer	2.63e-05	0.000173	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PPP2R1A—stomach cancer	2.62e-05	0.000172	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RPS6—stomach cancer	2.61e-05	0.000172	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HTR1A—stomach cancer	2.6e-05	0.000171	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALDOB—stomach cancer	2.59e-05	0.000171	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CA1—stomach cancer	2.59e-05	0.00017	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CKB—stomach cancer	2.59e-05	0.00017	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—FBP1—stomach cancer	2.59e-05	0.00017	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.59e-05	0.00017	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PRKCB—stomach cancer	2.57e-05	0.000169	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PPARG—stomach cancer	2.57e-05	0.000169	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6ST—stomach cancer	2.56e-05	0.000169	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PRKCB—stomach cancer	2.52e-05	0.000166	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ANXA1—stomach cancer	2.51e-05	0.000165	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.49e-05	0.000164	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—RHOA—stomach cancer	2.49e-05	0.000164	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PLIN2—stomach cancer	2.43e-05	0.00016	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SMAD4—stomach cancer	2.43e-05	0.00016	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRB1—stomach cancer	2.43e-05	0.00016	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALOX5—stomach cancer	2.41e-05	0.000159	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.41e-05	0.000159	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—CXCL8—stomach cancer	2.4e-05	0.000158	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HBEGF—stomach cancer	2.4e-05	0.000158	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—DPYD—stomach cancer	2.37e-05	0.000156	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CA2—stomach cancer	2.37e-05	0.000156	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RPS6—stomach cancer	2.32e-05	0.000153	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.32e-05	0.000153	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ALB—stomach cancer	2.31e-05	0.000152	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FYN—stomach cancer	2.31e-05	0.000152	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NT5E—stomach cancer	2.31e-05	0.000152	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PGAM1—stomach cancer	2.31e-05	0.000152	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6R—stomach cancer	2.29e-05	0.00015	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PRKCB—stomach cancer	2.28e-05	0.00015	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6ST—stomach cancer	2.28e-05	0.00015	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—RHOA—stomach cancer	2.27e-05	0.00015	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRB2—stomach cancer	2.22e-05	0.000146	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—NOS3—stomach cancer	2.21e-05	0.000145	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PLCE1—stomach cancer	2.2e-05	0.000145	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.2e-05	0.000145	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CXCL8—stomach cancer	2.18e-05	0.000144	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PPP2R1A—stomach cancer	2.17e-05	0.000143	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FGFR2—stomach cancer	2.17e-05	0.000143	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HBEGF—stomach cancer	2.13e-05	0.00014	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—UMPS—stomach cancer	2.11e-05	0.000139	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTT1—stomach cancer	2.1e-05	0.000138	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP2A6—stomach cancer	2.07e-05	0.000136	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—RHOA—stomach cancer	2.06e-05	0.000136	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6R—stomach cancer	2.03e-05	0.000134	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTGS2—stomach cancer	2.02e-05	0.000133	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—RHOA—stomach cancer	2.02e-05	0.000133	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKR1C3—stomach cancer	2.02e-05	0.000133	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SMAD4—stomach cancer	2.02e-05	0.000133	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CXCL8—stomach cancer	2e-05	0.000131	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IRS2—stomach cancer	1.98e-05	0.000131	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRB2—stomach cancer	1.97e-05	0.00013	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ENO1—stomach cancer	1.97e-05	0.000129	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PDHA1—stomach cancer	1.96e-05	0.000129	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ECHS1—stomach cancer	1.96e-05	0.000129	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PPP2R1A—stomach cancer	1.93e-05	0.000127	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CAV1—stomach cancer	1.92e-05	0.000127	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOA1—stomach cancer	1.92e-05	0.000126	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FYN—stomach cancer	1.91e-05	0.000126	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TYMP—stomach cancer	1.84e-05	0.000121	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—FADS1—stomach cancer	1.84e-05	0.000121	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.84e-05	0.000121	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—RHOA—stomach cancer	1.83e-05	0.000121	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PRKCB—stomach cancer	1.83e-05	0.00012	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6ST—stomach cancer	1.82e-05	0.00012	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CXCL8—stomach cancer	1.81e-05	0.000119	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FGFR2—stomach cancer	1.8e-05	0.000118	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SMAD4—stomach cancer	1.79e-05	0.000118	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CXCL8—stomach cancer	1.77e-05	0.000117	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APC—stomach cancer	1.75e-05	0.000115	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CD44—stomach cancer	1.74e-05	0.000115	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SREBF2—stomach cancer	1.73e-05	0.000114	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—RORA—stomach cancer	1.71e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FYN—stomach cancer	1.7e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—MAPK3—stomach cancer	1.68e-05	0.00011	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IRS2—stomach cancer	1.65e-05	0.000108	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6R—stomach cancer	1.63e-05	0.000107	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CXCL8—stomach cancer	1.61e-05	0.000106	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALDOB—stomach cancer	1.6e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	1.6e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—MAPK1—stomach cancer	1.6e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CAV1—stomach cancer	1.6e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—EGFR—stomach cancer	1.6e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOA1—stomach cancer	1.59e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CA—stomach cancer	1.53e-05	0.0001	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SERPINE1—stomach cancer	1.52e-05	0.0001	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PRKCB—stomach cancer	1.52e-05	0.0001	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6ST—stomach cancer	1.51e-05	9.96e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—KRAS—stomach cancer	1.51e-05	9.92e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALOX5—stomach cancer	1.49e-05	9.78e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.48e-05	9.76e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RHOA—stomach cancer	1.47e-05	9.67e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IRS2—stomach cancer	1.46e-05	9.62e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—DPYD—stomach cancer	1.46e-05	9.62e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTP1—stomach cancer	1.45e-05	9.57e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOS3—stomach cancer	1.45e-05	9.57e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APC—stomach cancer	1.45e-05	9.57e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMOX1—stomach cancer	1.43e-05	9.44e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CAV1—stomach cancer	1.42e-05	9.33e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOA1—stomach cancer	1.41e-05	9.31e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—MAPK3—stomach cancer	1.39e-05	9.16e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CA—stomach cancer	1.39e-05	9.12e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ERBB2—stomach cancer	1.36e-05	8.95e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TYMS—stomach cancer	1.35e-05	8.9e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6R—stomach cancer	1.35e-05	8.88e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	1.35e-05	8.88e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	1.34e-05	8.84e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTM1—stomach cancer	1.34e-05	8.79e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—MAPK1—stomach cancer	1.32e-05	8.72e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—EGFR—stomach cancer	1.32e-05	8.72e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTT1—stomach cancer	1.29e-05	8.51e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APC—stomach cancer	1.29e-05	8.5e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CXCL8—stomach cancer	1.29e-05	8.49e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HRAS—stomach cancer	1.28e-05	8.43e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.28e-05	8.41e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CA—stomach cancer	1.27e-05	8.33e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SERPINE1—stomach cancer	1.26e-05	8.32e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CDKN1B—stomach cancer	1.26e-05	8.29e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ERCC2—stomach cancer	1.26e-05	8.27e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—KRAS—stomach cancer	1.25e-05	8.23e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CA—stomach cancer	1.24e-05	8.18e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.24e-05	8.18e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	1.24e-05	8.14e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL6—stomach cancer	1.23e-05	8.07e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RHOA—stomach cancer	1.22e-05	8.03e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ENO1—stomach cancer	1.21e-05	7.97e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOS3—stomach cancer	1.21e-05	7.94e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCND1—stomach cancer	1.2e-05	7.91e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6R—stomach cancer	1.2e-05	7.89e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—JUN—stomach cancer	1.2e-05	7.89e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MTHFR—stomach cancer	1.18e-05	7.77e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	1.18e-05	7.74e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	1.18e-05	7.74e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MMP9—stomach cancer	1.17e-05	7.68e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CDKN1A—stomach cancer	1.16e-05	7.65e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CA—stomach cancer	1.15e-05	7.57e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK8—stomach cancer	1.13e-05	7.47e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	1.13e-05	7.43e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	1.12e-05	7.4e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	1.12e-05	7.39e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	1.11e-05	7.31e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CAV1—stomach cancer	1.09e-05	7.17e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOA1—stomach cancer	1.09e-05	7.15e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RHOA—stomach cancer	1.08e-05	7.13e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CD44—stomach cancer	1.07e-05	7.07e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOS3—stomach cancer	1.07e-05	7.05e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	1.07e-05	7.05e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	1.06e-05	7e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	1.05e-05	6.89e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	1.05e-05	6.88e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—STAT3—stomach cancer	1.04e-05	6.83e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	1.02e-05	6.72e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6—stomach cancer	1.02e-05	6.7e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	1e-05	6.6e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCND1—stomach cancer	9.97e-06	6.56e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—JUN—stomach cancer	9.95e-06	6.55e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	9.91e-06	6.52e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP9—stomach cancer	9.68e-06	6.37e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	9.65e-06	6.35e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MYC—stomach cancer	9.64e-06	6.34e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARG—stomach cancer	9.58e-06	6.3e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	9.51e-06	6.26e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	9.45e-06	6.22e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	9.43e-06	6.21e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EGFR—stomach cancer	9.43e-06	6.2e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	9.42e-06	6.2e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	9.29e-06	6.11e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	9.13e-06	6.01e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6—stomach cancer	9.04e-06	5.95e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTP1—stomach cancer	8.96e-06	5.9e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KRAS—stomach cancer	8.91e-06	5.86e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCND1—stomach cancer	8.86e-06	5.83e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—JUN—stomach cancer	8.84e-06	5.82e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMOX1—stomach cancer	8.84e-06	5.81e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	8.69e-06	5.72e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALB—stomach cancer	8.61e-06	5.67e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—STAT3—stomach cancer	8.61e-06	5.67e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP9—stomach cancer	8.6e-06	5.66e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	8.57e-06	5.64e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	8.36e-06	5.5e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TYMS—stomach cancer	8.33e-06	5.48e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NOS3—stomach cancer	8.24e-06	5.42e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTM1—stomach cancer	8.23e-06	5.42e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	8.23e-06	5.41e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	8.18e-06	5.38e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MYC—stomach cancer	8e-06	5.26e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TP53—stomach cancer	7.92e-06	5.21e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	7.83e-06	5.15e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EGFR—stomach cancer	7.82e-06	5.15e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ERCC2—stomach cancer	7.74e-06	5.09e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	7.72e-06	5.08e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—STAT3—stomach cancer	7.65e-06	5.03e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HRAS—stomach cancer	7.57e-06	4.98e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS2—stomach cancer	7.53e-06	4.96e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KRAS—stomach cancer	7.39e-06	4.86e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	7.31e-06	4.81e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MTHFR—stomach cancer	7.28e-06	4.79e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6—stomach cancer	7.25e-06	4.77e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MYC—stomach cancer	7.11e-06	4.68e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	6.95e-06	4.57e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EGFR—stomach cancer	6.95e-06	4.57e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	6.79e-06	4.47e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CAV1—stomach cancer	6.71e-06	4.42e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOA1—stomach cancer	6.7e-06	4.41e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TP53—stomach cancer	6.57e-06	4.32e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KRAS—stomach cancer	6.57e-06	4.32e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HRAS—stomach cancer	6.28e-06	4.13e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	6.03e-06	3.97e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6—stomach cancer	6.01e-06	3.96e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARG—stomach cancer	5.9e-06	3.88e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TP53—stomach cancer	5.84e-06	3.84e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HRAS—stomach cancer	5.58e-06	3.67e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6—stomach cancer	5.34e-06	3.52e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALB—stomach cancer	5.31e-06	3.49e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NOS3—stomach cancer	5.07e-06	3.34e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS2—stomach cancer	4.64e-06	3.05e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CA—stomach cancer	4.64e-06	3.05e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.86e-06	1.88e-05	CbGpPWpGaD
